Skin pigmentation refers to a skin disorder that causes either lightening of skin or darkening of skin when compared to the existing skin color. In general, hyperpigmentary disorder relates to darkening of skin and hypopigmentation means lightening of skin color.
Pigmentation disorders affect the skin color causing skin appear as discolored and blotchy. Color of skin is regulated by a skin component called melanin which is produced by some special cells present in the body. Pigmentation is caused due to minimal or excessive production of melanin owing to the damaged or unhealthy melanin producing cells.
Melanin protects our skin from sun induced skin cancer and prevents the sunlight to penetrate deep into the skin by acting as an as an absorbent filter for UV-Rays. The most common pigmentation disorders are melasma (hyperpigmentary disorder), vitiligo (hypopigmentary), albinism (inherited rare disorder) and post inflammatory hyperpigmentation. Melasma occurs due to the hormonal changes such as pregnancy, oral contraception; and after the sun exposure that increases the melanin concentration in the skin.
Get Sample Copy of this Report @ https://www.persistencemarketresearch.com/samples/17350
The global market for pigmentation disorder treatment is segmented on basis of disease indication, treatment type, distributor channel and geographic region:
Segmentation by Disease Indication
- Melasma
- Vitiligo
- Albinism
- Post-inflammatory hyperpigmentation
Segmentation by Treatment Type
- Pharmacological Treatment
- Topical drugs
- Hydroquinone
- Azelaic Acid
- L-Ascorbic Acid
- others
- Cosmetic Treatment
- Chemical Peel
- Laser Therapy
- Dermabrasion
- Skin Grafting
- others
Segmentation by Distribution Channel
- Dermatology Clinics
- Aesthetic Clinics
- Drugstores and Cosmetic Stores
- E-commerce
- Others
Segmentation by Geography
- North America
- Latin America
- Europe
- Asia-Pacific
- Middle East & Africa
For the entire list of market players, request for Table of Content here @ https://www.persistencemarketresearch.com/toc/17350
In USA, 5 – 6 million women are affected by melasma which comprises 80% of pregnant women in Mexico and 50-75% pregnant women in USA. However, vitiligo is an acquired skin disorder caused by depigmentation or lightening of skin.
Individuals with over exposure to sun, hormonal changes, stress and overuse of cosmetics and hair dyes are more susceptible to higher risks of skin pigmentation disorders. Also, genetics and heredity are some of the reasons behind skin pigmentation.
Skin pigmentation treatment is of extreme importance as people are more concerned to improve the appearance of affected skin. In order to treat a skin pigmentation disorder, a physician or dermatologist uses 2 approaches that include: pharmacological treatment using topical drugs, hydroquinone, azelaic acid, L-ascorbic acid and cosmetic treatment using chemical peels, laser therapy, dermabrasion and skin grafting.
On the basis of type of treatment, cosmetic treatment techniques are extensively used over other treatment types as cosmetic therapies are bound to give quick and effective results. Also, rising demand for skin brightening products from customer end is anticipated to propel the pigmentation disorder treatment market over the forecast period.
Pre-Book Right Now for Exclusive Analyst Support @ https://www.persistencemarketresearch.com/checkout/17350
Some of the key players present in global pigmentation disorder treatment market are Episciences, Inc., La Roche-Posay, Bayer AG, Allergan, Inc., SkinCeuticals International, Pierre Fabre Laboratories, Alvogen, Inc., Obagi Medical Products Inc., and others.
About us: Persistence Market Research
Contact us:
Persistence Market Research
Address – 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com